Posizioni attive di Greg Misson
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Eqalis Pharmaceuticals Ltd
 Eqalis Pharmaceuticals Ltd Pharmaceuticals: MajorHealth Technology Part of Cannasouth Ltd., Eqalis Pharmaceuticals Ltd is a New Zealander company that manufactures cannabis-based pharmaceuticals. The company is based in Katikati, New Zealand. The CEO of the company is Greg Misson. Eqalis Pharmaceuticals was acquired by Cannasouth Ltd. on May 24, 2023 for $27.30 million. | Amministratore Delegato | - | - |
Storia della carriera di Greg Misson
Precedenti posizioni note di Greg Misson
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CANNASOUTH LIMITED | Direttore/Membro del Consiglio | - | 05/01/2024 |
| Direttore Tecnico/Scientifico/R&S | - | - |
Statistiche
Distribuzione geografica
| Nuova-Zelanda | 3 |
Posizioni
| Chief Executive Officer | 1 |
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Settori
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CANNASOUTH LIMITED | Health Technology |
| Aziende private | 1 |
|---|---|
Eqalis Pharmaceuticals Ltd
Eqalis Pharmaceuticals Ltd Pharmaceuticals: MajorHealth Technology Part of Cannasouth Ltd., Eqalis Pharmaceuticals Ltd is a New Zealander company that manufactures cannabis-based pharmaceuticals. The company is based in Katikati, New Zealand. The CEO of the company is Greg Misson. Eqalis Pharmaceuticals was acquired by Cannasouth Ltd. on May 24, 2023 for $27.30 million. | Health Technology |
- Borsa valori
- Insiders
- Greg Misson
- Esperienza
